MarketInOut Stock Screener Log In | Sign Up
 

PRF Technologies Ltd

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026
PRF Technologies Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2.59 mln
Float3.04 mln
Earnings Date04/01/2027

Piotroski F-Score

5 / 9
Neutral

Relative Strength

17 / 100
Significantly lagging

Debt / Equity

0.00
Debt-free

Pre-Tax Margin

-18,174%
Severely loss-making

ROE

-48.56
Deeply negative

Altman Z-Score

-7.7
Deeply distressed

Business Description

PRF Technologies Ltd. (formerly PainReform Ltd.) is an Israeli clinical-stage pharmaceutical company focused on improving existing pain medications to make them work longer and more effectively after surgery. Its lead product, PRF-110, is an oil-based solution applied directly to a surgical wound to deliver extended local pain relief without the need for systemic drugs. The company is currently running Phase 3 clinical trials for patients recovering from bunion removal and hernia repair surgeries. Founded in 2007 and headquartered in Tel Aviv-Yafo, Israel, PRF Technologies aims to reduce reliance on traditional painkillers during post-operative recovery.

Key Fundamentals

EPS-4.09
ROE-48.56
RPS0.03
ROIC-66.62
ROA-37.77
EBITDA, mln-4.57
EV / EBITDA2.32
EV / EBIT1.88
Revenue, mln0.03

Quote Details

Last 0.74
Change 0.0199 (2.76%)
Open 0.7161
Volume 54,718
Turnover 40,491
Average Volume 33,741

Financial Ratios

Pre-Tax Profit Margin-18,174
Leverage Ratio1.20
Current Ratio5.07
Price / Book0.17
Price / Tangible Book0.30
Debt / Equity0.00
Price / Sales29.67

Financial Strength

Altman Z-Score-7.7
Piotroski F-Score 5 / 9
Short Ratio0.07
Short % of Float0.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.3% 16 / 100   
1 Month -24.65% 15 / 100   
2 Months -35.65% 14 / 100   
6 Months -67.54% 7 / 100   
1 Year -87.77% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog